Laboratory Considerations for Clinical Trials
Science:Life Sciences
In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in clinical trials for biotech companies.
Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a new approach.
Alex and Alan talk about:
- How different risks are evaluated and prioritized and the processes put in place to mitigate and/or respond to those risks if they occur.
- What sponsors can do to reduce the risks for their study
- How Q2 Solutions' in-house scientific and regulatory expertise ensure that your data are compliant to global regulations
You can learn more at https://q2labsolutions.com/biotech.
More Episodes
Flexible Approaches for Biotech Companies in Clinical Trials
2022-06-22
223
2022-06-22
223
Managing Sample Data from Vendors
2021-09-14
215
2021-09-14
215
Automation within an ADME Laboratory
2021-08-26
198
2021-08-26
198
Bioanalytical Automation of Samples
2021-07-30
167
2021-07-30
167
Consent Tracking for Clinical Samples
2021-07-28
165
2021-07-28
165
Tracking Clinical Trial Samples
2021-07-28
158
2021-07-28
158
Avoiding Canceled Tests in Pediatric Samples
2021-02-02
139
2021-02-02
139
Covid Vaccine Testing
2020-09-15
186
2020-09-15
186
Hybrid Assays for Protein Bioanalysis
2020-07-29
148
2020-07-29
148
High Throughput ADME Testing
2020-07-29
95
2020-07-29
95
Liquid Biopsy Collection in Clinical Development Programs
2020-07-29
116
2020-07-29
116
Companion Diagnostic Strategies for Commercial Success
2019-02-26
196
2019-02-26
196
Get this podcast on your
phone, FREE
